AIxBio

AI and biotechnology risks

SecureBio AI: 2025 in Review

2025 was a significant year for the SecureBio AI team – reflected by the fact that we tripled our headcount, adding to our roster of world-class…

Feb 17 • SecureBio

SecureBio Selected to Develop Bio-Evals for the European Commission

We’re excited to share that the European Commission’s AI Office has chosen SecureBio to develop biological threat evaluations (‘evals’) to support the…

Feb 3 • SecureBio

SecureBio’s AI Team: An Overview of Our Biorisk Evaluations

A lot of AI safety work never makes headlines, but it’s quietly shaping model deployment decisions at the highest levels.

Jun 4, 2025 • SecureBio

AIs can provide expert-level virology assistance

When we set out to test if LLMs can match virologists on troubleshooting complex virology lab scenarios, we didn’t expect to find that they had already…

Apr 23, 2025 • Jasper Götting

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts